Zentalis Pharmaceuticals, Inc. - Common Stock,$0.001 par value per share (ZNTL)

CUSIP: 98943L107

Q2 2024 13F Holders as of 30 Jun 2024

Holder snapshot 7 signals
Share change
-8,743,532
Put/Call ratio
11%
SEC-reported price per share
$4.09
Number of holders
142
Value change
-$54,359,485
Number of buys
78
Open additional details 1 more signal available
Number of sells
64
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
72,096,078

Security key

98943L107

Report period

Q2 2024

Institutions

142

Top holders

10

Ownership snapshot

Top reported holders of ZNTL - Zentalis Pharmaceuticals, Inc. - Common Stock,$0.001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Matrix Capital Management...
Disclosed value leader
Matrix Capital Management...
Comparable rows
15/15
Latest evidence
31 Mar 2024
13F Lead comparable stake: 19% Showing 1-6 of 15 holder rows.

Quick read

Matrix Capital Management Company, LP leads the comparable SEC ownership view at 19%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Matrix Capital Management Company, LP's linked filing trail.
Comparable ownership Top 5
Matrix Capital Management Company... 19%
EVENTIDE ASSET MANAGEMENT, LLC 16%
FMR LLC 15%
BlackRock Finance, Inc. 6.4%
VANGUARD GROUP INC 6.1%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Matrix Capital Management Company, LP
13F
Company
13F
19%
$220,009,174
13,959,973 shares
31 Mar 2024
EVENTIDE ASSET MANAGEMENT, LLC
13F
Company
13F
16%
$182,419,179
11,574,821 shares
31 Mar 2024
FMR LLC
13F
Company
13F
15%
$167,749,818
10,644,024 shares
31 Mar 2024
BlackRock Finance, Inc.
13F
Company
13F
6.4%
$73,217,147
4,645,758 shares
31 Mar 2024
VANGUARD GROUP INC
13F
Company
13F
6.1%
$69,322,330
4,398,625 shares
31 Mar 2024
CITADEL ADVISORS LLC
13F
Company
13F
5.3%
$60,714,281
3,852,429 shares
31 Mar 2024
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
142
Shares
76,565,937
Rows available
142
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2024 vs Q1 2024 Across Filers

Q1 2024 holders
140
Q2 2024 holders
142
Holder diff
2
Investor Q1 2024 Shares Q2 2024 Shares Share Diff Share Chg % Q1 2024 value Q2 2024 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .